bpc-157 legal status fda 2026 An Committee Just Voted in Favor of Peptides—Despite the Agency's Opposition FDA to weigh easing limits

measured B12 levels in 51 mothers, placentas, and infants post-delivery, and found that the intervillous space in the placenta contained a higher concentration of B12 (796 pmol/l) than the blood of the mothers (590 pmol/l) or their newborns (252 pmol/l)

The primary endpoints that track response to MOTS-c therapy align with the peptide's core mechanisms: insulin sensitivity, mitochondrial function, body composition, and inflammatory tone

This is qualitatively different from what anti-inflammatory medications produce, because the tissue itself is changing rather than just the symptom signal being blocked

B12 injections do not directly melt fat or force the body to lose weight on its own

These findings are documented but derive predominantly from animal studies and should be interpreted accordingly